vimarsana.com
Home
Live Updates
Update on Favorable Legal and Regulatory Outcomes Clearing P
Update on Favorable Legal and Regulatory Outcomes Clearing P
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
On March 28, Judge Andrews removed the injunction issued in the Original Hatch Waxman LitigationOn March 29, Judge Bates denied United Therapeutics’ motion for temporary restraining order and...
Related Keywords
District Of Columbia ,
United States ,
Delaware ,
America ,
Roger Jeffs ,
Jason Adair ,
Drug Administration ,
Us District Court ,
District Of Delaware Court ,
Company Contacts ,
Delaware District Court Case No ,
Liquidia Corporation ,
Liquidia Technologies Inc ,
Judge Andrews ,
Original Hatch Waxman ,
Judge Bates ,
United Therapeutic ,
United Therapeutics ,
District Court ,
Original Hatch Waxman Litigation ,
New Drug Application ,
Chief Executive Officer ,
Judge Andrew ,
Delaware District Court ,
Dry Powder Inhalation ,
Open Label Prospective Multicenter Study ,
Evaluate Safety ,
Dry Powder Inhaled Treprostinil ,
Pulmonary Hypertension ,
Liquidia Technologies ,
Private Securities Litigation Reform Act ,
Markets ,